AXSM
#970
Axsome Therapeutics, Inc. - Common Stock
162.2 2 USD
+0.04%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+3.77%
Changement Mensuel
-20.75%
Evolution sur 6 mois
-11.36%
Changement Annuel
+24.59%
Clôture Précédente
156.3 2
Open
156.4 1
Low
155.1 8
High
164.0 0
Financials
- Market Capitalization 8.5 B
- Employee 925
- Founded 2012
- CEO Herriot Tabuteau
- Website www.axsome.com
- Headquarter Delaware, United States
- FIGI BBG00B6G7GL7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-49.63
ratio cours/chiffre d'affaires
14.23
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 952 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 136.28 USD | -1.60% | -2.36% | -5.49% | +81.39% | 8.82 B USD | ||
| 953 |  CYTK Cytokinetics, Incorporated - Common Stock | 63.43 USD | +2.94% | +5.17% | -8.76% | +9.17% | 8.82 B USD | ||
| 985 |  TGTX TG Therapeutics, Inc. - Common Stock | 54.37 USD | +0.06% | +1.93% | +2.35% | +55.65% | 8.32 B USD | ||
| 988 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 58.37 USD | +0.41% | -3.58% | -17.10% | +49.28% | 8.25 B USD |